Furthermore, we revealed that NSUN2-mediated m5C modification could promote glycolysis and the progression of HCC by upregulating PKM2, which provides a potential prognostic factor and therapeutic target for HCC patients and is bound to constitute a breakthrough in clinical and experimental research. This evidence concerns the gene PKM and hepatocellular carcinoma.